Skip to main content
Caplight Logo









Canid

Canid

Private
New York City, New YorkHealthcare & Life Scienceshttps://canid.io/

Last Round

Series A

Jun 3, 2025

Total Funding Raised

$12.9M

Company Overview

Canid is a healthtech company that provides a vaccine workflow automation and management platform designed to streamline pediatric vaccine management.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, EHR & EMR, Patient Engagement, Compliance

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

vaccine managementvaccine-as-a-servicerevenue cycle managementRCMpediatric practice managementvertical SaaSEHR integrationvaccines for childrenVFCmedical billing automationhealthcare workflow automationinventory managementpatient outreachhealthtechpractice management software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Canid Comparables

Compare Canid with similar companies based on industry and business-model similarity.

Canid comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VaxCare
78%
PhysicianXpress
78%
Office Practicum
74%

Canid Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 3, 2025
SeedSep 21, 2023
SeedMar 1, 2021

Key People

Founding team and executive leadership

Pedro Sanchez de Lozada

Founder & CEO

Founding Team

Juliana Muñoz

Chief Operating Officer

Executive Team

Canid Investors

Notable investors and investment history

Canid investors
InvestorRounds
MKT1Seed
I2BF Global VenturesSeed
MKT1 CapitalSeed
SeedtoB CapitalSeries A, Seed
FJ LabsSeries A, Seed
Brooklyn Bridge VenturesSeries A, Seed
Alumni VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 82% MoM, from 1.7K to 3K.

  • Feb 1, 2026

    Added Celebration Pediatrics Llc as a customer.

Canid Filings

Explore SEC and related filing metadata, where available.

Canid filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Canid's valuation, stock price, and market status.

Is Canid a public or private company?

Canid is a private company.

What is the current stock price of Canid?

Canid is a private company with no public stock price. No recent secondary market data is available.

How much is Canid worth (valuation)?

Valuation information for Canid is not publicly available.

Can I buy Canid stock?

Canid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Canid's last funding round?

Canid's most recent funding round was Series A on June 3, 2025.

Who are the main investors in Canid?

Key investors in Canid include SeedtoB Capital, Telescope Partners.

Will Canid IPO soon?

No public IPO plans have been announced for Canid.

How can I track Canid secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Canid's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range61
Year Founded2021
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?